Safety And Effectiveness of Autologous Platelet Rich Plasma Therapy For Lateral Epicondylitis: Systematic Reviews

Research purposes: To explore the clinical effect of local injection of autologous platelet-rich plasma (platelet-rich plasma) for lateral epicondylitis of humerus. Research method: A total of 58 patients with lateral epicondylitis of the humerus who were treated in the orthopedics department of our hospital from January 2018 to December 2018 were selected and included in the study. Subjects were treated with local injection of autologous platelet-rich plasma. Before the treatment, at 1 week, 1 month and 3 months after the treatment, the subjects were evaluated with visual analogue scale (VAS) and Mayo elbow function score (MEPS) for pain and elbow function. Results: Compared with before treatment, VAS decreased and MEPS increased after treatment. The four indicators of MEPS—pain, activity, stability, and daily abilities were significantly improved. Conclusion: Local injection of autologous PRP in the treatment of lateral epicondylitis of the humerus can better relieve pain symptoms and improve elbow joint function.

Download Full-text

Autologous platelet-rich plasma therapy — a promising method for tissue repair/ /regeneration in many medical fields

Journal of Transfusion Medicine ◽

10.5603/jtm.2020.0004 ◽

2020 ◽

Vol 13 (2) ◽

pp. 135-148

Author(s):

Łukasz Piszczorowicz ◽

Dorota Król ◽

Stanisław Dyląg

Keyword(s):

Tissue Repair ◽

Platelet Rich Plasma ◽

Promising Method ◽

Plasma Therapy ◽

Autologous Platelet Rich Plasma ◽

Autologous Platelet

Download Full-text

“ROLE OF AUTOLOGOUS PLATELET RICH PLASMA THERAPY IN TREATMENT OF PLANTAR FASCIITIS, A PROSPECTIVE STUDY.”

10.36106/ijsr/8004567 ◽

2021 ◽

pp. 51-52

Author(s):

Kashif Iqbal ◽

Vivek Kumar ◽

Himanshu Patel ◽

Anurag Tiwari

Keyword(s):

Plantar Fasciitis ◽

Platelet Rich Plasma ◽

Corticosteroid Injection ◽

Case Series ◽

Small Sample ◽

Treatment Modalities ◽

Post Injection ◽

Plasma Therapy ◽

Autologous Platelet Rich Plasma ◽

Autologous Platelet

Plantar fasciitis is fairly common in orthopaedics out-patient department. Although, majority of the patients do well with conservative treatment, some patients continue to have painful feet despite a course of conservative management. These patients of plantar fasciitis are provided with other treatment modalities such as local corticosteroid but the chronic condition requires multiple dosages and are associated with adverse reaction. Autologous platelet rich plasma therapy is another modality for treatment of such cases and are not associated with adverse effects when compared with corticosteroid injection therapy. This prospective case series analyses the improvement of pain using visual analogue scale of plantar fasciitis patients treated with autologous platelet rich plasma over the course of 3 months. 30 patients were enrolled in the study. The mean VAS score at pre injection was 7.13 which signicantly reduced to 3.3 at 6 weeks post injection and 2.36 at 6 weeks post injection. There was signicant improvement in pain. This study is limited with small sample size and short follow up.

Download Full-text

Efficacy, safety and tolerability of autologous platelet rich plasma injection in the treatment of lateral epicondylitis

International Journal of Research in Orthopaedics ◽

10.18203/issn.2455-4510.intjresorthop20194817 ◽

2019 ◽

Vol 5 (6) ◽

pp. 1121

Author(s):

Kavyansh Bhan ◽

Randhir Kenjle

Keyword(s):

Performance Index ◽

Statistical Difference ◽

Platelet Rich Plasma ◽

Lateral Epicondylitis ◽

Base Line ◽

The Novel ◽

Methyl Prednisolone ◽

Plasma Injection ◽

Autologous Platelet Rich Plasma ◽

Autologous Platelet

Background: To evaluate the effects of platelet-rich plasma (PRP) infiltration in patients with lateral epicondylitis of the elbow.Methods: A randomized, prospective study on 60 patients with lateral epicondylitis of the elbow was conducted at Ruby Hall Clinic, Pune. The patients were randomized and evaluated after receiving infiltration of three milliliters of PRP, or methyl prednisolone. The base-line evaluation was done using visual analog score (VAS) and modified Mayo performance index for elbow (MAYO). Re-evaluation was after 1 and 6 months of the procedure. Statistical analysis was done using independent t-test.Results: After 6 months of treatment with PRP, patients with lateral epicondylitis had a statistically significant improvement in their VAS (p<0.05) in contrast to steroid. However, no statistical difference in modified Mayo performance index was found between the two groups at 1 and 6 months after intervention.Conclusions: Treatment of patients with lateral epicondylitis with PRP reduces pain and is better tolerated than steroid therapy. Thus, the novel PRP therapy can be considered as a primary approach to treat patients of lateral epicondylitis conservatively.

Download Full-text